Boston-based Company Provides Epidemiological and Analytic expertise
to Federal, Commercial and International Clients
MCLEAN, Va.--(BUSINESS WIRE)--
Booz Allen Hamilton today announced that it has acquired Boston,
MA.-based Epidemico, Inc., a move that underscores the firm's commitment
to further develop leading edge analytic capabilities in critical areas
such as population health.
Epidemico is an informatics company providing early insights, continuous
monitoring and consumer engagement for varied aspects of population
health, including disease outbreaks, drug safety, supply chain
vulnerabilities and more. By combining innovative data acquisition and
analysis technologies with public health expertise, Epidemico delivers
sophisticated surveillance systems and consumer-centric engagement tools.
"The acquisition of Epidemico aligns closely with our Vision 2020
long-term growth strategy, expanding our client offerings with some
truly leading capabilities and products that will drive growth
opportunities," said Booz Allen President and Chief Operating Officer
Horacio Rozanski. "The addition of Epidemico's analytic capabilities to
our data science team builds on the firm's broader strategy of expanding
its engineering and technology expertise to respond to the changing
demands of government and commercial clients seeking more cost-effective
and innovative solutions."
Epidemico, with a staff of industry recognized epidemiologists and
health leaders, is known for pioneering global population health
solutions that radically disrupt traditional detection, reporting and
engagement systems. For example, one of Epidemico's commercially
licensed products, HealthMap, leads the field in digital disease
detection tracking over 200 infectious diseases worldwide in 15
different languages.
Epidemico's suite of cloud-based solutions serve as trusted resources
for the public, government officials, life science, financial and
Fortune 500 companies both in the U.S. and internationally. Several
products are also directly supported by government entities such as the
Food and Drug Administration, Centers for Disease Control and Department
of Homeland Security. The company's work has been nationally recognized
by the Smithsonian Institution and the Library of Congress as well as
media, including the New York Times, NBC and CNN.
The team at Epidemico, which is a commercial spinoff of Boston
Children's Hospital, Harvard Medical School and the Massachusetts
Institute of Technology, has a deep understanding of how to extract
value from multiple large data sets and a proven ability to translate
that expertise into a rapidly growing business. Likewise, the
proprietary software platform is transferrable to multiple industries
and business use cases. The combination of Epidemico with Booz Allen's
world class data science capability, and federal and commercial health
teams enhances the firm's collective ability to support a broad set of
client needs.
"Being part of Booz Allen Hamilton is very exciting for us," said
Epidemico President and Chief Operating Officer Robin Heffernan. "The
teaming works on many levels - overlapping expertise, synergistic
product/service mix, and a shared collaborative spirit. This combination
will accelerate the development of comprehensive, integrated solutions
that will enhance value to clients in both the short and longer-term."
"This acquisition is perfectly aligned to Booz Allen's Innovation
agenda, adding a creative and successful start-up to our firm," said
Executive Vice President Karen Dahut, who leads the firm's Strategic
Innovation Group. "Their set of successful products, with several
popular social media feeds, will also accelerate our efforts to develop
alternative revenue streams for Booz Allen."
Executive Vice President Fred Blackburn, who oversees Booz Allen's
NextGen Analytics Initiative, noted how this acquisition fits "as a
critical first step in our broader strategy of growth through organic
and inorganic investment - building a full portfolio of analytic
platforms and solutions to address the critical need for improved
analytics and data science across our client base. We believe that the
Health analytics space is the ideal place to begin executing that
strategy, given its obvious importance to the population, as well as the
associated business opportunities."
Information about Epidemico is available at http://epidemico.com/.
About Booz Allen Hamilton
Booz Allen Hamilton is a leading provider of management consulting,
technology, and engineering services to the U.S. government in defense,
intelligence, and civil markets, and to major corporations,
institutions, and not-for-profit organizations. Booz Allen is
headquartered in McLean, Virginia, employs more than 22,000 people, and
had revenue of $5.48 billion for the 12 months ended March 31, 2014.
BAHPR-FI
Booz Allen Hamilton
Media Relations
James Fisher, 703-377-7595
or
Investor
Relations
Curt Riggle, 703-377-5332
Source: Booz Allen Hamilton
News Provided by Acquire Media
